ArticleJournal of robotic surgery2025
A novel robot-assisted subretinal injection system: preliminary validation in ex vivo porcine eyes.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- SS-OCT-guided dual-arm master-slave robotic system for in vivo subretinal injection in porcine eyes.Journal of robotic surgery · 2026Article
- Cell therapy for age-related macular degeneration.Mammalian genome : official journal of the International Mammalian Genome Society · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To evaluate the application of a novel, partially automated, robot-assisted ophthalmic surgery for subretinal injection, a study was conducted comparing manual and robot-assisted injections performed by doctors of varying experience levels on fresh, isolated porcine eyes. This system was developed by a team from Harbin Institute of Technology. The core component is a specialized microneedle with adjustable puncture angle and integrated force-sensing capability. It enables flexible intraocular manipulation during subretinal injection procedures and performs autonomous retinal puncture guided by force feedback. Results showed that robot-assisted injections by all doctors achieved a 100% success rate without safety events such as retinal laceration or RPE penetration. While the senior doctor exhibited the highest manual injection success rate and lowest safety event probability, medical students showed the opposite. Compared to manual injection, robot-assisted injection demonstrated smaller needle force variation, more regular retinal "bubble" shape, and more stable subretinal fluid volume (p < 0.05). The surgical robot can accurately perform automatic subretinal injection with high success and good safety, potentially shortening the learning curve and replacing manual operation in the future.
Indexed as
Identifiers
40637923What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.